Eyeonix AIQ adds Rohit Chitale and Grigoris Gerotziafas to board
Eyeonix AIQ (EAIQ) announced the addition of Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors, effective October 16, 2026. The company did not disclose reasons or committee changes.
How this was made

The 30-second read
Why it matters
The board change does not introduce new financial data or operational changes, limiting immediate trading relevance.
Market read
A standard board appointment filing with limited immediate market impact.
What to watch
Potential future strategic shifts driven by the new board members are not evident yet.
Background
Eyeonix AIQ is a provider of AI‑driven analytics solutions; the filing is a routine corporate governance update.
Ticker impact
Eyeonix AIQ filed an 8‑K announcing the addition of Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board, effective immediately.
neutral as no immediate catalyst
The filing provides no financial numbers or strategic changes; market typically treats board additions as informational with limited price effect.
Market effects
Minimal impact on the AI/analytics sector; no new product or partnership disclosed.
None
Low
Counterpoint
If investors view the new directors as high‑profile hires, a modest upside could emerge.
Key entities
- CompanyEyeonix AIQ, Inc.
AI analytics firm filing the 8‑K.
- PersonRohit Chitale
New board director.
- PersonGrigoris Gerotziafas
New board director.



